IB

Imshu Bansal

Active Director Director DIN 08740406
DIN 08740406 First appointment May 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2020
Shareholding value •••• Premium profile

About Imshu Bansal

Data last updated:

Imshu Bansal is a Director at Synergy Mediplus Private Limited (since 2020). The company operates in Pharma. Synergy Mediplus Private Limited reported revenue of ₹5.30 Cr (FY 2024).

DIN 08740406
Primary Designation Director
Industry Pharma
First Appointment 08 May 2020
Oldest Company Age 6 yrs
Largest company Synergy Mediplus Private Limited · ₹5.30 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synergy Mediplus Private Limited U51397RJ2020PTC068769
Director08 May 20202020₹5.30 Cr (FY 2024)Active

Board colleagues of Imshu Bansal

Directorship timeline

Open interactive timeline →
Synergy Mediplus Private Limited
Premium access

Shareholding and investment profile for Imshu Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Imshu Bansal

Imshu Bansal currently holds 1 directorship: Synergy Mediplus Private Limited (Director, since 08 May 2020, revenue ₹5.30 Cr (FY 2024)).

Imshu Bansal was first appointed on 08 May 2020 as Director at Synergy Mediplus Private Limited.

The current boards of Imshu Bansal's companies include Anuj Bansal (Synergy Mediplus Private Limited), Nitin Jagetiya (Synergy Mediplus Private Limited), Shruti Jagetia (Synergy Mediplus Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available